Coronavirus Information Session Monday, March 2, 4:00 pm Program - - PowerPoint PPT Presentation

▶
coronavirus information session
SMART_READER_LITE
LIVE PREVIEW

Coronavirus Information Session Monday, March 2, 4:00 pm Program - - PowerPoint PPT Presentation

May 20, 2023 30 likes •326 views

Coronavirus Information Session Monday, March 2, 4:00 pm Program Title: Coronavirus Information Session Attendee Dial In Number: 866-342-8588 or 203-518-9865 Passcode/ID: 92489 1 Agenda Start Time Topic Presenter 3:45 p.m. Line opens for

slide-1
SLIDE 1

Coronavirus Information Session

Monday, March 2, 4:00 pm

Program Title: Coronavirus Information Session Attendee Dial In Number: 866-342-8588 or 203-518-9865 Passcode/ID: 92489

1

slide-2
SLIDE 2

Agenda

Start Time Topic Presenter 3:45 p.m. Line opens for callers 4:00 p.m. Introduction Bob Garrett 4:05 p.m. Virus Update

  • Dr. Jerry Zuckerman

4:20 p.m. CDI Research and Support

  • Dr. David Perlin

4:25 p.m. Operational Response Mark Stauder

  • Dr. Dan Varga

Bob Glenning 4:40 p.m. Communications Response Dorie Klissas 4:45 p.m. Participant Q&A 5:00 p.m. Event concludes

2

slide-3
SLIDE 3

Introduction

Bob Garrett

3

slide-4
SLIDE 4

Virus Update

Jerry Zuckerman

4

slide-5
SLIDE 5

Coronavirus

  • Enveloped non-segmented positive-sense RNA viruses
  • Distributed broadly among humans, other mammals,

birds

  • Human coronaviruses:
  • hCOV-229E, OC43, NL63, HKU1
  • Mild upper respiratory tract illnesses
  • Part of the rapid respiratory panel test

5

slide-6
SLIDE 6

Zoonotic Coronavirus Outbreaks

Severe acute respiratory syndrome (SARS-CoV)

  • 2002-03 Guangdong Province, China
  • 8100 confirmed cases; 774 deaths
  • Animal reservoir: Palm Civets
  • Natural host: Bats
  • Mortality rate 10%

6

Middle East respiratory syndrome (MERS-CoV)

  • Outbreaks 2012 -> present
  • As of 11/2019: 2494 confirmed

cases, 858 deaths

  • Epicenter Saudi Arabia
  • Animal reservoir: Dromedary Camels
  • Limited chains of human transmission
  • Mortality rate 37%
slide-7
SLIDE 7

COVID-19 (SARS-CoV-2) Timeline

12/31/19 27 cases viral pneumonia in Wuhan, China reported to WHO 1/7/20 novel coronavirus identified (SARS-CoV-2) 2/20- 2/21/20 Cases reported in Iran and Italy 2/19/20 Outbreak in South Korean religious sect 3/1/20 Totals 88,000 Cases 3,000 Deaths

https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases

7

1/30/20 Public Health Emergency

  • f International Concern
slide-8
SLIDE 8

8

COVID-19 Timeline

slide-9
SLIDE 9

R0 – Basic Reproduction Number

https://www.nytimes.com/interactive/2020/world/asia/china-coronavirus-contain.html Accessed 2/3/20

9

COVID-19 R0 and Mortality Rate Est.

slide-10
SLIDE 10

COVID-19: Clinical Course Patterns

  • Mild illness with upper respiratory tract presenting

symptoms (81%)

  • Non-life-threatening pneumonia (14%)
  • Severe pneumonia with acute respiratory distress

syndrome (ARDS) (5%)

  • Onset around day 7 of illness
  • Rapid deterioration

10

slide-11
SLIDE 11

Emerging Infectious Diseases

SARs 2002 MERs 2012 Pandemic H1N1 2019 Ebola 2014 COVID-19 2020

Human Transmission Sustained Limited Sustained Limited Sustained Transmission Respiratory Respiratory Respiratory Body Fluids Respiratory Symptom Onset Abrupt Abrupt Insidious Abrupt Insidious Infectivity Symptom

  • nset

Symptom

  • nset

Before symptom

  • nset

Symptom

  • nset

Before symptom

  • nset

Immunity None None Partial None None U.S. Cases 27 2 60.8 million 11 ???? U.S. Deaths 12,500 2 ????

11

slide-12
SLIDE 12

CDI Research and Support

  • Dr. David Perlin

12

slide-13
SLIDE 13

Why Coronavirus Diagnostics Matter

  • Clinical characteristics (e.g. acute upper or lower respiratory tract

distress) are non-specific

  • A confirmatory diagnosis better supports clinical management and

better clinical outcome

  • Specific diagnostics are needed to track virus within the healthcare

setting and the community

13

slide-14
SLIDE 14

How are Coronaviruses Detected?

  • Molecular diagnostics are used to detect RNA sequences specific to

COVID-19.

  • The tests are rapid and sensitive, and can provide real-time information

within hours.

What if a Patient’s Sample Tests Positive?

  • The Lab/Infection Control will contact the State Health Department and

the CDC, and the sample will be confirmed by a national/local CDC- designated reference laboratory.

  • The patient will be managed as a positive case, unless further testing

proves negative.

14

slide-15
SLIDE 15

COVID-19 Molecular Detection Assay

Virus particles Break open virus and isolate RNA Convert RNA to DNA

Amplify DNA

Detect COVI-19 specific sequences Real-time quantitative detection

15

slide-16
SLIDE 16

Operational Response

Mark Stauder

16

slide-17
SLIDE 17

Operational & Preparedness Response

Steering Committee - Chair, Mark Stauder

  • Incident Command Structure – Development of Clinical and

Operational Subcommittees with Task Forces led by Subject Matter Experts

  • Network Command Center – Open 24/7 as of 3/2/20
  • Operational Preparedness Subcommittees
  • Co-chairs: Dr. Siddiqui and K. Haber
  • Clinical Access and Care Delivery Subcommittee
  • Co-chairs: Dr. Varga, Theresa Brodrick, Dr. Zuckerman

17

slide-18
SLIDE 18

COVID-19 Committee Structure

Operations Subcommittee Chair

  • Deeba Siddiqui & Ken Haber

Task Forces Include:

  • Emergency Management – Ken Haber
  • Materials Management – Mike Goolsby
  • Pharmaceuticals – Rich Epstein
  • Occupational Health/HR – Landa Poiani

Darocki & Mark Coleman

  • Laboratory – Sean Fitzgerald
  • Communications – Jim Blazar
  • Pandemic Plan – Ken Haber
  • Ambulatory Practices – Christine Devine

Clinical Access & Delivery Subcommittee Chairs

  • Dr. Daniel Varga, Theresa Brodrick & Dr. Jerry

Zuckerman Task Forces Include:

  • Infection Control – Jerry Zuckerman
  • Diagnostics – David Perlin
  • Communications – Jim Blazar
  • IT/EPIC – Dr. Lauren Koniaris

18

slide-19
SLIDE 19

NJ DOH & NJHA: Partners for COVID-19 Response

Structure: 3 Centers in Tandem

  • 1. Regional Operations & Intelligence Center: ROIC
  • New Jersey State Command Center which will be activated at the Governor’s direction
  • 1a. State Emergency Operations Center: SEOC
  • Subcommittee of the ROIC
  • Actively monitoring potential pandemic and the impact to New Jersey residents
  • Assessing Surge Capabilities across the State
  • 2. New Jersey Hospital Association: NJHA currently activated
  • Emergency Management Division of NJHA is the primary call center for any preparedness-related questions
  • Act as a conduit to the Assistant Commissioner of Health at the NJDOH
  • Information gathering from WHO and CDC
  • Coordination with OSHA
  • Monitoring of Supply Chain Issues
  • 3. Local Public Health Departments
  • Primary contact for patient screening, surveillance, and testing

19

slide-20
SLIDE 20

Preparedness Activities

Emergency Management

  • Incident Command Structure established 2/1/20; Command Center 3/2/20
  • Task Forces mobilized
  • Facility Surge Plans: Space, Staffing, Supplies, 7 Tents & 3 Trailers secured
  • Telemedicine & Home Monitoring solutions will be activated
  • Negative Pressure Room Inventory
  • Ability to scale up at Pascack Valley Medical Center; 41 medical-surgical beds and 9 critical care beds

Infection Prevention

  • Screening protocols – EPIC and paper
  • Isolation protocols – EPIC - ED, Inpatient, Ambulatory
  • Education/in-services (Donning/Doffing, etc.)

Materials management

  • Inventory of personal protective equipment, respiratory equipment, and disinfectants
  • 153,000 N95 respirators on hand
  • Procurement and conservation of supplies – pandemic supplies
  • Pharmaceuticals – antivirals secured
  • Clinical equipment and evaluation – i.e. 200 IV pumps secured

20

slide-21
SLIDE 21

Preparedness Activities

Diagnostics

  • Diagnostic Lab Assay to be implemented this week in collaboration with Center for Discovery and

Innovation Occupational Health/HR

  • Management of HMH TMs returning from China -> 14 day leave and active symptomatic monitoring
  • Fit testing strategy
  • Tele-work strategy

Ambulatory Practices

  • Identify, Isolate, and Transfer (Home or ED) Workflows created
  • Supplies inventory

Communication

  • Daily situation updates across the Network
  • Communication Strategy, Trees & Emergency Notification
  • Intranet site established with protocols, links, FAQs

21

slide-22
SLIDE 22

Preparedness Activities

Develop Network Surge Management Strategy

  • Access
  • Care Delivery
  • Alternate Care Sites: Tents, MSED Units

Deploy MSED Units

22

slide-23
SLIDE 23

Purchasing and Other Preparedness Activities

Bob Glenning

23

slide-24
SLIDE 24

Communications Response

Dorie Klissas

24

slide-25
SLIDE 25

Internal Communications

Timely, consistent communications issued since January 24.

COVID-19 Resource Center is updated daily and available through the HMH internet homepage and intranets. Leveraging existing communication vehicles to provide regular updates to team members. Leaders receive daily updates for their Safety Huddles from Infection Prevention & Control.

25

slide-26
SLIDE 26

Urgent Updates

Communications tree created. Email inbox created for team member questions and concerns. All team member communications sent when updates are pertinent.

26

slide-27
SLIDE 27

Patient Communications

27

slide-28
SLIDE 28

Media Coverage

28

slide-29
SLIDE 29

Participant Q&A

29